Paucibacillary Leprosy

Paucibacillary leprosy is a type of leprosy with fewer than six skin spots. It's classified based on the number of skin spots and if the bacteria are found in the skin. This type of leprosy usually needs less intensive treatment with antibiotics. It's a less severe form of the infection.

Condition

What people with Paucibacillary Leprosy report

Every report comes from a Lived member, sent anonymously.

Have you tried Rifampin for Paucibacillary Leprosy?

NameHow it went

About Paucibacillary Leprosy

What It Is

Paucibacillary leprosy is the milder, more limited form of leprosy, also called Hansen's disease. Leprosy is a long-lasting bacterial infection caused by Mycobacterium leprae, which mainly affects the skin and the nerves that run to the hands, feet and face. "Paucibacillary" means "few bacteria": the label covers leprosy with one to five skin patches and no bacteria visible on a skin smear, a lab test that looks for the organism in a small scraping of skin. The typical sign is a small number of pale or reddish skin patches where feeling is reduced or lost, so a touch, a pinprick or heat registers less than on normal skin. A nearby nerve may become thickened, tender or weak. This form occurs when the immune system responds strongly enough to keep the bacteria in check, which is why the disease stays limited. Paucibacillary leprosy is a treatment grouping rather than a single disease type: it includes the forms doctors call indeterminate, tuberculoid and borderline tuberculoid leprosy. It matters because leprosy is curable, but untreated nerve damage can become permanent, leaving numb or weak hands and feet that are easily injured.

Causes & Risk Factors

Leprosy is caused only by infection with Mycobacterium leprae. It is believed to spread through droplets from the nose and mouth of a person with untreated leprosy, and only after prolonged, close contact over many months, such as within a household. It does not spread through casual contact like shaking hands, hugging, sharing a meal or sitting next to someone, and a person stops passing it on once treatment begins. Most people are naturally protected: around 95% of people cannot get leprosy because their immune system fights off the bacteria. The main risk factor is having lived in a country where leprosy is still common, such as India, Brazil or Indonesia. In the United States the disease is rare, and most people diagnosed here were infected abroad. Some armadillos in the southern United States carry the bacteria, and several US cases were likely acquired from them, although the risk from this source is very low. The bacteria grow very slowly, so signs can appear years after exposure, in some cases up to 20 years later.

How It's Diagnosed

Leprosy is usually recognized by examination. A clinician looks for at least one of its cardinal signs: a pale or reddish skin patch with definite loss of feeling, a thickened nerve with numbness or muscle weakness in the area it supplies, or bacteria seen under the microscope in a skin smear. Testing sensation with a light touch, a pin or a fine nylon filament, and feeling the nerves at the elbows, knees and neck, are part of the exam. In the United States, the diagnosis is confirmed with a skin or nerve biopsy, in which a small sample is examined with a special stain that shows these bacteria. The count of skin patches, the skin smear and the biopsy decide whether the disease is paucibacillary or multibacillary (the more widespread form with many bacteria). Getting this right matters: someone with multibacillary disease who is treated as paucibacillary may receive too short a course, which raises the risk of the infection coming back.

Treatment Options

Leprosy is curable with a combination of antibiotics called multidrug therapy. Using several drugs together kills the bacteria and prevents them from becoming resistant to any one medicine. Starting early matters because the antibiotics stop the infection, while nerve damage that builds up before treatment can be permanent. The World Health Organization recommends three medicines, dapsone, rifampicin (called rifampin in the US) and clofazimine, taken for 6 months for paucibacillary disease. In the United States, the National Hansen's Disease Program (NHDP) recommends a longer course of daily rifampin and dapsone for 12 months, without clofazimine. The NHDP runs specialized outpatient clinics across the country and publishes treatment guidance for clinicians. Dapsone is an older antibiotic that can break down red blood cells, especially in people with an inherited enzyme shortage called glucose-6-phosphate dehydrogenase (G6PD) deficiency, and in rare cases it seriously lowers white blood cell counts. For that reason, blood counts are checked regularly during treatment. Rifampin and dapsone each have their own side effects and interactions, which the prescriber reviews before starting. Treatment also includes protecting the nerves. If a reaction inflames a nerve, corticosteroids such as prednisone are the main treatment for a severe episode, often tapered over several months, and resting the affected limb in a splint can protect the nerve while it settles.

What to Expect

Once treatment starts, a person is no longer considered contagious and can usually continue work, school and family life. The main daily commitment is taking the medicines every day for the full course, along with regular visits for blood tests and nerve checks. The most important thing to watch for is a reaction, an inflammatory flare caused by the immune system attacking the bacteria. In borderline tuberculoid leprosy, these type 1 or reversal reactions are most common in the first 6 months of treatment, but they can happen before treatment, during it or even after it has finished. Existing patches may become red, swollen and warm, and nerves may become painful or lose function. A reaction is not a sign that treatment has failed or an allergy to the antibiotics, and the antibiotics are usually continued while the reaction is treated. When an area of skin is numb, burns, cuts and pressure sores on the hands and feet can go unnoticed, and painless sores on the soles are a known complication, so looking over numb areas and protecting them from injury becomes part of routine life. Many people also face stigma, which can affect relationships and emotional wellbeing; accurate information about how rarely leprosy spreads and how fully it can be treated often helps.

When to Seek Help

Arrange a medical evaluation for a skin patch, pale or reddish, that does not go away and feels numb or less sensitive than the surrounding skin, particularly if you have lived in a country where leprosy is common or have had close contact with armadillos. Ask about referral to the National Hansen's Disease Program if your clinician is unfamiliar with the disease. During or after treatment, contact your care team promptly, ideally the same day, if you notice pain or tenderness along a nerve, new numbness or weakness in a hand, foot or the face, existing patches suddenly becoming red and swollen, or sudden swelling of the hands, feet or face. These are signs of a reaction, and early treatment can prevent permanent nerve damage. While taking dapsone, also report a fever, sore throat, unusual paleness, unexplained bruising or yellowing of the skin or eyes right away.

Questions to Ask Your Doctor

  1. 1.How confident are we that this is paucibacillary rather than multibacillary disease, and what tests confirmed it?
  2. 2.Which treatment regimen will I follow, how long will it last, and how will we check that it is working?
  3. 3.Should my household or close contacts be examined?
  4. 4.How will we monitor my nerves, and what should I do if I notice new numbness, weakness or pain?
  5. 5.How should I protect areas of skin that have lost feeling?

Last reviewed • Oct 2026

Educational content, not medical advice.